SPX5,074.08-322.44 -5.97%
DIA383.22-22.00 -5.43%
IXIC15,587.79-962.82 -5.82%

Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $16

Benzinga·04/01/2025 14:11:23
Listen to the news
Barclays analyst Michael Leithead maintains Chemours (NYSE:CC) with a Equal-Weight and lowers the price target from $19 to $16.